“…histamine shows a 10 nM K A s against hCAs VA and XIV but is a micromolar activator of the remaining isoforms) 1 . The molecule of histamine has been extensively modified ( Figure 3 ), including substituents on the imidazole C atoms ( A ) 41 , 42 , replacing the imidazole ring with other heterocycles, such as 2,4,6-trisubstituted pyridinium ( B ), 1,3,4-thiadiazole ( C ) or a combination of these two ring systems ( D ) 43 , 44 and functionalising the NH 2 group, as in carboxamides/ureas/thioureas ( E ) 45 , sulphonamides ( F ) 46 , arylsulfonylureas ( G ) 47 , bis-histamine ( H ) 48 , 49 , oligopeptides 49 , 50 , or imidazole/imidazoline derivatives of the alkaloyd spinaceamine 51 , 52 and drug clonidine 53 ( Figure 3 ) were reported to possess improved CA activatory profile when potency and isoform selectivity are concerned.…”